Physician profile
Daniel Roshan
NPI 1225025547
$2,166.96
in general payments reported to CMS, 2019-2025
19 companies · $336 in 2025
The $336 reported for 2025 was more than what 87% of Maternal & Fetal Medicine providers received nationally (typical 2025 total: $55.21).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $711 · 2020: $35.44 · 2021: $435 · 2022: $156 · 2023: $250 · 2024: $244 · 2025: $336.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $829.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $829.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $330.31 | 2023-2025 | Freestyle Libre 3, Eterna |
| Roche Diagnostics Corporation | $315.73 | 2019 | |
| Alydia Health | $279.25 | 2021 | |
| Corcept Therapeutics | $202.57 | 2025 | Korlym |
| Abbvie INC. | $150.00 | 2019 | |
| Ge Healthcare | $145.89 | 2021-2024 | |
| Coopersurgical, INC. | $141.90 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $124.85 | 2023 | |
| Vifor Pharma, INC. | $121.95 | 2019 | |
| Hologic Sales and Service, LLC | $89.91 | 2019-2025 | Aptima |
| Exeltis, USA INC. | $76.48 | 2022-2025 | Slynd |
| Myovant Sciences INC. | $39.00 | 2021-2022 | |
| Millicent US INC | $35.44 | 2020 | |
| Vertos Medical, INC. | $26.50 | 2021 | |
| Evofem Biosciences, INC. | $22.15 | 2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $19.99 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.15 | 2019 | |
| Vertical Pharmaceuticals, LLC | $15.90 | 2019 | |
| Avion Pharmaceuticals | $12.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Roshan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.